Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: polyrotaxanes

March 10, 2026 CD as API / CD derivatives / Pharma applications

Toxic effects and cellular uptake of functional polyrotaxanes. The little we have learned and the many unknowns still waiting to be discovered.

Cyclodextrins are commonly used as excipients in modern drug delivery, but they also have a less common role as active

Continue reading

November 12, 2025 CD as API / CD derivatives / Pharma applications

Methyl BCD-based supramolecular polyrotaxane as theranostic in anticancer immunotherapy

Despite the tremendous therapeutic promise of activating stimulators of interferon genes (STING) enable to prime robust de novo T-cell responses,

Continue reading

April 29, 2024 CD derivatives / Drug delivery / Pharma applications

Synthesis of cyclodextrin-based polyrotaxanes and polycatenanes for supramolecular pharmaceutical sciences

This nicely illustrated review article summarizes the syntheses and structural analyses of CD polyrotaxanes and polycatenanes to facilitate their applications

Continue reading

June 24, 2022 Events / Non-pharma applications / Other industrial use

Prof. Kohzo Ito at ICS 20

Kohzo Ito, professor at Tokyo University and director of Advanced Softmaterials Inc. gave a plenary lecture on the 20th International

Continue reading

July 20, 2021 Drug delivery / Pharma applications

Age-related ocular conditions: Current treatments and role of cyclodextrin-based nanotherapies

Age-related eye disorders are chronic diseases that affect millions of people worldwide. They cause visual impairment and, in some cases,

Continue reading

December 6, 2019 Drug delivery / Pharma applications

Bio-soft cyclodextrin materials

A recent review of prof. Mazzaglia’s group gives an overview on CD-based nanomaterials of biological relevance focusing on CD self-assembly

Continue reading

Recent Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering
  • Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin complexation of selected tyrosine kinase inhibitors

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (784)
  • E-ducation (63)
  • Environmental (132)
  • Events (233)
  • Food (219)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,172)
  • Supramolecular systems (40)
  • Uncategorized (143)

Top Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin-in-Liposome for therapy: Advances and challenges
  • Pilocarpine eye drops (Vuity)
  • Lanosterol eye drops for cataract treatment
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • CDs for the removal of PFAS; A review
  • Appropriate Dosing of Sugammadex in Morbidly Obese Patients
  • Cyclodextrins Meet Cosmetics, a review
  • Water-Soluble EDTA-Crosslinked Poly-β-Cyclodextrins as Ion-Complexing Drug Carriers.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...